tradingkey.logo

Atara Biotherapeutics Inc - On March 31, Entered Amendment To Commercialization Agreement With Pierre Fabre - SEC Filing

ReutersApr 4, 2025 10:05 PM

- Atara Biotherapeutics Inc ATRA.O:

  • ATARA BIOTHERAPEUTICS INC - ON MARCH 31, ENTERED AMENDMENT TO COMMERCIALIZATION AGREEMENT WITH PIERRE FABRE - SEC FILING

  • ATARA BIOTHERAPEUTICS INC - BIO TO RECEIVE UP TO $550 MILLION IN MILESTONE PAYMENTS - SEC FILING

  • ATARA BIOTHERAPEUTICS INC - PIERRE FABRE TO ASSUME COSTS FOR FDA REMEDIATION TO SUPPORT BLA RESUBMISSION FOR TAB-CEL - SEC FILING

Source text: [ID:n0000950170-25-051121]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI